a2M email response;
Hi Bronwyn,
Thank you for your message.
As per recentNZX/ASX releases made by the Company, the infant formula regulatory environment in China continues to evolve, however, the Company considers itself well placed to respond to changes in regulation in conjunction with its manufacturing partner.
A summary of the China regulatory issues under review can be found on page 22 of the First NZ Capital & Credit Suisse Dairy Day 2016 Presentation released to market on Wednesday 6 April 2016. It can be accessed from the company's investor Centre.
The Company will continue to monitor regulatory changes, whilst ensuring it complies with its continuous disclosure obligations.
Regards,
The a2 Team
The a2Milk Company
- Forums
- ASX - By Stock
- A2M
- Explain China new tax policy and formula registration with CFDA
Explain China new tax policy and formula registration with CFDA, page-87
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add A2M (ASX) to my watchlist
(20min delay)
|
|||||
Last
$6.85 |
Change
-0.030(0.44%) |
Mkt cap ! $4.959B |
Open | High | Low | Value | Volume |
$6.93 | $6.98 | $6.83 | $5.841M | 844.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
20 | 12971 | $6.85 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$6.86 | 8670 | 18 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
22 | 14547 | 6.850 |
24 | 35095 | 6.840 |
19 | 36427 | 6.830 |
12 | 20993 | 6.820 |
11 | 14249 | 6.810 |
Price($) | Vol. | No. |
---|---|---|
6.860 | 5697 | 13 |
6.870 | 14942 | 22 |
6.880 | 28280 | 20 |
6.890 | 30002 | 13 |
6.900 | 33076 | 15 |
Last trade - 14.22pm 15/07/2024 (20 minute delay) ? |
Featured News
A2M (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online